β Home
βΉοΈ Info
π§Ύ At a Glance π Core Facts ποΈ Products/Services β Ratings π§βπΌ Executives π¬ My Commentsπ‘ Analytics
π Insights π’ Company Q&A (663) π οΈ Industry Q&A (164) π Competitors π Price Low π Price Swings β‘ SWOT ποΈ PEST π Porter's Five Forces β¨ Score Positive β οΈ Risk Assessment π§© Segmentation π Ά Google Linksπ Ratios
π° Margins π Financial Ratios π± Growth π Enterprise Value π Key Metrics π΅ Dividendsπ§ Tools
β Due Diligenceπ Core Facts
| CEO | Pablo Legorreta |
| Employees | 75 |
| Phone | 212 883 0200 |
| Address | 110 East 59th Street New York City NY 10022 US |
| IPO Date | 2020-06-16 |
| Average Volumes | 3704624 |
| Market Cap | 20.689 B USD |
| Div >7% since | N/A |
| Web | https://www.royaltypharma.com |
| ISIN | GB00BMVP7Y09 |
| NASDAQ ticker | RPRX |
| News on YouTube | YouTube |
| SEC | 'Royalty Pharma' on SEC |
| Reports | 'Royalty Pharma' Reports |
| CUSIP | G7709Q104 |
